Browsing by Author Cervantes Requena, F.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 11 of 11
Issue DateTitleAuthor(s)
11-Jun-2015A pooled analysis of overall survival in COMFORT-I and COMFORT-II, 2 randomized phase III trials of ruxolitinib for the treatment of myelofibrosis.Vannucchi, Alessandro M.; Kantarjian, Hagop M.; Kiladjian, Jean-Jacques; Gotlib, Jason; Cervantes Requena, F.; Mesa, Ruben A.; Sarlis, Nicholas J.; Peng, Wei; Sandor, Victor; Gopalakrishna, Prashanth; Hmissi, Abdel; Stalbovskaya, Viktoriya; Gupta, Vikas; Harrison, Claire N.; Verstovsek, Srdan; García Pagán, Juan Carlos
1-Aug-2016Antiplatelet therapy versus observation in low-risk essential thrombocythemia with CALR mutationÁlvarez Larrán, Alberto; Pereira Saavedra, Arturo; Guglielmelli, Paola; Hernández Boluda, Juan Carlos; Arellano Rodrigo, Eduardo; Ferrer Marín, Francisca; Samah, Alimam; Griesshammer, Martin; Kerguelen Fuentes, Ana; Andreasson, Bjorn; Burgaleta, Carmen; Schwarz, Jiri; García Gutiérrez, Valentín; Ayala, Rosa; Barba, Pere; Gómez Casares, María Teresa; Paoli, Chiara; Drexler, Beatrice; Zweegman, Sonja; McMullin, Mary F.; Samuelsson, Jan; Harrison, Claire N.; Cervantes Requena, F.; Vannucchi, Alessandro M.; Besses, Carlos
1-Jan-2017Associations between gender, disease features and symptom burden in the MPN population: An analysis by the MPN QOL International Working GroupGeyer, Holly L.; Kosiorek, Heidi; Dueck, Amylou C.; Scherber, Robyn; Slot, Stefanie; Zweegman, Sonja; Te Boekhorst, Peter A.; Senyak, Zhenya; Schouten, Harry C.; Sackmann, Federico; Kerguelen Fuentes, Ana; Hernández-Maraver, Dolores; Pahl, Heike L.; Griesshammer, Martin; Stegelmann, Frank; Döhner, Konstanze; Lehmann, Thomas; Bonatz, Karin; Reiter, Andreas; Boyer, Francoise; Etienne, Gabriel; Ianotto, Jean-Christophe; Ranta, Dana; Roy, Lydia; Cahn, Jean-Yves; Harrison, Claire N.; Radia, Deepti; Muxi, Pablo; Maldonado, Norman; Besses, Carlos; Cervantes Requena, F.; Johansson, Peter L.; Barbui, Tiziano; Barosi, Giovanni; Vannucchi, Alessandro M.; Paoli, Chiara; Passamonti, Francesco; Andreasson, Bjorn; Ferrari, Maria L.; Rambaldi, Alessandro; Samuelsson, Jan; Cannon, Keith; Birgegard, Gunnar; Xiao, Zhijian; Xu, Zefeng; Zhang, Yue; Sun, Xiujuan; Xu, Junqing; Kiladjian, Jean-Jacques; Zhang, Peihong; Gale, Robert Peter; Mesa, Ruben A.
Feb-2014Comparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studiesMesa, Ruben A.; Kiladjian, Jean-Jacques; Verstovsek, Srdan; Al-Ali, Haifa Kathrin; Gotlib, Jason; Gisslinger, Heinz; Levy, Richard; Siulnik, Andres; Gupta, Vikas; Khan, Mahmudul; DiPersio, John F.; McQuitty, Mari; Catalano, John V.; Hunter, Deborah S.; Knoops, Laurent; Deininger, Michael W.; Cervantes Requena, F.; Miller, Carole; Vannucchi, Alessandro M.; Silver, Richard T.; Barbui, Tiziano; Talpaz, Moshe; Barosi, Giovanni; Winton, Elliott F.; Mendeson, Estella; Harvey, Jimmie H.Jr.; Arcasoy, Murat O.; Hexner, Elizabeth; Lyons, Roger M.; Paquette, Ronald; Raza, Azra; Sun, William; Sandor, Victor; Kantarjian, Hagop M.; Harrison, Claire N.
1-Oct-1985Linfomas no hodgkinianos de histología 'favorable'. Respuesta al tratamiento y supervivenciaGardella Company, Santi; Montserrat Costa, Emilio; Rozman, Ciril, 1929-; Llebaria Regalado, Carlos A.; Diumenjó Riveros, Maria Cristina; Olivé, Teresa; Bladé, J. (Joan); Cervantes Requena, F.; Feliu Frasnedo, Evaristo; Grañena Batista, Alberto; Marín, Pedro; Nomdedeu, Benet; Brugués, Rosa
9-Mar-2017Long-term outcomes of imatinib treatment for chronic myeloid leukemia.Hochhaus, Andreas; Larson, Richard A.; Guilhot, François; Radich, Jerald P.; Branford, Susan; Hughes, Timothy P.; Baccarani, Michele; Deininger, Michael W.; Cervantes Requena, F.; Fujihara, Satoko; Ortmann, Christine E.; Menssen, Hans D.; Kantarjian, Hagop M.; O'Brien, Stephen G.; Druker, Brian J.
24-Apr-2008Papel de la activación leucocitaria y plaquetaria en la trombosis de los síndromes mieloproliferativos crónicosÁlvarez Larrán, Alberto
7-Sep-2009Papel de la activación plaquetaria y leucocitaria en la patogenia de la trombosis en la trombocitemia esencialArellano Rodrigo, Eduardo
30-Jun-2005Papel de los genes P16 y survivina en la progresión de la leucemia mieloide crónica a la crisis blásticaHernández Boluda, Juan Carlos
5-Feb-2014Safety and efficacy of switching to nilotinib 400 mg twice daily for patients with chronic myeloid leukemia in chronic phase with suboptimal response or failure on frontline imatinib or nilotinib 300 mg twice daily.Hughes, Timothy P.; Hochhaus, Andreas; Kantarjian, Hagop M.; Cervantes Requena, F.; Guilhot, François; Niederwieser, Dietger; le Coutre, Philipp D.; Rosti, Gianantonio; Ossenkoppele, Gert J.; Lobo, Clarisse; Shibayama, Hirohiko; Fan, Xiaolin; Menssen, Hans D.; Kemp, Charisse; Larson, Richard A.; Saglio, Giuseppe
1-Jan-2016Symptomatic profiles of 1334 polycythemia vera patients: implications of inadequately controlled diseaseGeyer, Holly L.; Scherber, Robyn; Kosiorek, Heidi; Dueck, Amylou C.; Kiladjian, Jean-Jacques; Xiao, Zhijian; Slot, Stefanie; Zweegman, Sonja; Sackmann, Federico; Kerguelen Fuentes, Ana; Hernández-Maraver, Dolores; Döhner, Konstanze; Harrison, Claire N.; Radia, Deepti; Muxi, Pablo; Besses, Carlos; Cervantes Requena, F.; Johansson, Peter L.; Andreasson, Bjorn; Rambaldi, Alessandro; Barbui, Tiziano; Bonatz, Karin; Reiter, Andreas; Boyer, Francoise; Etienne, Gabriel; Ianotto, Jean-Christophe; Ranta, Dana; Roy, Lydia; Cahn, Jean-Yves; Maldonado, Norman; Barosi, Giovanni; Ferrari, Maria L.; Gale, Robert Peter; Birgegard, Gunnar; Xu, Zefeng; Zhang, Yue; Sun, Xiujuan; Xu, Junqing; Zhang, Peihong; Te Boekhorst, Peter A.; Commandeur, Suzan; Schouten, Harry C.; Pahl, Heike L.; Griesshammer, Martin; Stegelmann, Frank; Lehmann, Thomas; Senyak, Zhenya; Vannucchi, Alessandro M.; Passamonti, Francesco; Samuelsson, Jan; Mesa, Ruben A.